RGS
Pharmaceuticals, Biotechnology & Life Sciences
Regeneus
- Short interest
- 0.02%
- as of 6 Feb 2020
- Reported shorts
- 60.2K
- Shares on issue
- 277.825M
Regeneus (RGS) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for RGS (last checked 15 Oct 2026).